ONCTOncternal Therapeutics Inc

$0.61
$0.1673
(24.11%)
Today
Closed $0.5266
$0.0834
(15.84%)
After Hours
Updated: 07:24 PM EST
Reported EarningsAug 8
Mkt Cap$1.56M
Vol702,150.00
23

Extremely Bearish Sentiment

How do you feel about ONCT?

About

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Oncternal Therapeutics Inc?
What is the 52-week high for Oncternal Therapeutics Inc?
What is the 52-week low for Oncternal Therapeutics Inc?
What is Oncternal Therapeutics Inc stock price today?
What was Oncternal Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Oncternal Therapeutics Inc?

Latest ONCT News

View
Top Discussions

Advertisement|Remove ads.